{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:56Z","timestamp":1788871916740,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012628","name":"Japan Epilepsy Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.braindev.2011.09.003","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T12:17:53Z","timestamp":1318853873000},"page":"496-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis"],"prefix":"10.1016","volume":"34","author":[{"given":"Yukiko","family":"Mogami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumiko","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Shigematu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2011.09.003_b0100","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/7010.2006.00223","article-title":"Clinical characteristics and prognostic factors of postencephalitic epilepsy in children","volume":"12","author":"Chen","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2011.09.003_b0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejpn.2007.02.011","article-title":"Risk factors for postencephalitic epilepsy in children: a hospital-based study in Taiwan","volume":"5","author":"Lee","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2011.09.003_b0015","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1440-1819.2004.01244_3.x","article-title":"Etiologic factors and clinical features of symptomatic epilepsy: focus on pediatric cases","volume":"58","author":"Fujiwara","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.braindev.2011.09.003_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cyto.2004.03.012","article-title":"Analysis of cytokine levels and NF-\u03baB activation in peripheral blood mononuclear cells in influenza virus-associated encephalopathy","volume":"27","author":"Ichiyama","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.braindev.2011.09.003_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cyto.2008.07.002","article-title":"Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis","volume":"44","author":"Ichiyama","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.braindev.2011.09.003_b0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1212\/01.WNL.0000086819.53078.70","article-title":"Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua","volume":"61","author":"Takahashi","year":"2003","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1016\/j.braindev.2011.09.003_b0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1528-1167.2005.01024.x","article-title":"Autoantibodies and cell-mediated autoimmunity to NMDA-type GluR2 in patients with Rasmussen\u2019s encephalitis -and chronic progressive epilepsia partialis continua","volume":"46","author":"Takahashi","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.09.003_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2011.09.003_b0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-3-642-00663-0_8","article-title":"The role of cytokines in the mechanism of adverse drug reactions","volume":"196","author":"Masson","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.braindev.2011.09.003_b0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.09.003_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reaction","volume":"51","author":"Ikeda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.09.003_b0060","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","article-title":"JSAR research group. HLA-B 1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients","volume":"51","author":"Kaniwa","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2011.09.003_b0065","first-page":"1","article-title":"Genome-wide association study of serious blistering skin rash caused by drugs","author":"Shen","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.braindev.2011.09.003_b0090","unstructured":"Takahashi Y, Ikeda H, Yamasaki E, Tsunogae H, Nishimura S. Severe cutaneous adverse reaction by antiepileptic drugs, -etiology, HLA, and serum biomarkers- (in Japanese). In Report of the Health and Labor Sciences Research Grant (Research on Advanced Medical Technology) from the Ministry of Health, Labor and Welfare; 2009. p. 55\u201362."},{"key":"10.1016\/j.braindev.2011.09.003_b0070","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"20","author":"Arif","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.09.003_b0075","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.braindev.2011.09.003_b0080","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-4632.2010.04785.x","article-title":"Severe adverse cutaneous drug eruptions: epidemiological and clinical features","volume":"50","author":"Zaraa","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.braindev.2011.09.003_b0085","first-page":"1737","article-title":"Encephalitis and encephalopathy involved by autoimmunity","volume":"51","author":"Takahashi","year":"2010","journal-title":"Shonika (Tokyo)"},{"key":"10.1016\/j.braindev.2011.09.003_b0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1248\/bpb.31.299","article-title":"Comparative study of usefulness of the drug-induced lymphocyte stimulation test and the leukocyte migration test in drug allergies","volume":"31","author":"Saito","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.braindev.2011.09.003_b0005","doi-asserted-by":"crossref","first-page":"12107","DOI":"10.1128\/JVI.78.22.12107-12119.2004","article-title":"Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection","volume":"78","author":"Chen","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.braindev.2011.09.003_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-2478(97)00034-5","article-title":"Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES","volume":"58","author":"Conti","year":"1997","journal-title":"Immunol Lett"},{"key":"10.1016\/j.braindev.2011.09.003_b0110","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/JVI.74.3.1415-1424.2000","article-title":"A Central role for CD4+ T cells and RANTES in virus-induced central nerve system inflammation and demyelination","volume":"74","author":"Lane","year":"2000","journal-title":"J Virol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411002506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760411002506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:47:16Z","timestamp":1759952836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760411002506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0387760411002506"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2011.09.003","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous adverse drug reaction in patients with epilepsy after acute encephalitis","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2011.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}